CNS Pharmaceuticals to Present at the LSX World Congress 2024

20h ago, source:

HOUSTON, TX / ACCESSWIRE / April 23, 2024 / (NASDAQ:CNSP)("CNS" or the "Company"), a biopharmaceutical company specializing ...

Tinygemsbreaks CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO To Present At LSX World Congress 2024

5h ago, source:

CNS Pharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic canc ...

Biomednewsbreaks CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Spotlighted In Upcoming Virtual Investor Lunch Break Event

1d ago, source:

CNS Pharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic canc ...

CNS Pharmaceuticals Reports Full Year 2023 Financial Results and Highlights Recent Corporate and Clinical Achievements

22d ago, source: Nasdaq

About CNS Pharmaceuticals, Inc.CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic ...

CNS Pharmaceuticals Inc Ordinary Shares CNSP

6d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Sage Therapeutics gets grant for treatment of CNS-related conditions using compound of formula (b)

20h ago, source: Pharmaceutical Technology

Discover how Sage Therapeutics Inc's patent for compounds can revolutionize CNS-related treatment. From anxiety to schizophrenia, this method offers hope.

CNS Pharmaceuticals Reports Full Year 2023 Financial Results and Highlights Recent Corporate and Clinical Achievements

23d ago, source: Stockhouse

About CNS Pharmaceuticals, Inc. CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers ...

CNS Pharmaceuticals Inc.

27d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

CNS Pharmaceuticals, Inc.: CNS Pharmaceuticals to Present at the LSX World Congress 2024

19h ago, source:

HOUSTON, TX / ACCESSWIRE / April 23, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing ...